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Although not in routine use, molecular techniques appear able to detect small numbers of solid tumor cells in blood, lymph nodes, and bone marrow (for review see 1) . Provided that a given mRNA is expressed exclusively in tumor tissue and not by nucleated blood cells, lymph node cells, or bone marrow cells, its presence outside the organ identifies disseminated metastatic cells. In prostate cancer (CaP), early detection of metastases by molecular staging could help in selecting which patients would benefit most from surgical therapy [2] .
Several reverse transcriptase-polymerase chain reaction (RT-PCR) protocols are able to amplify the mRNAs encoding prostate-specific antigen (PSA) or prostate-specific membrane antigen (PSMA) in blood [1] , lymph nodes [3] , or bone marrow [4] . Nevertheless, the results reported have varied so widely (e.g., positive PSA RT-PCR results ranging from 25% [5] to 80% [6] for metastatic CaP patients) that definitive conclusions about the clinical relevance of this new molecular tool have not yet been established. The heterogeneity of both preanalytical and analytical steps of PCR protocols may explain the discrepancies observed between studies. To our knowledge, no systematic studies of the successive steps of the RT-PCR method have yet been performed. To better standardize the assay, we have assessed the effects of the storage conditions of blood samples and delay before processing.
To compare the effect of delayed vs immediate sample processing, we collected 250-mL blood samples in 25 10-mL EDTA-treated tubes (Becton Dickinson) from 4 apparently healthy blood donors. Each sample was then supplemented with 10 5 metastatic lymph-node-derived prostate carcinoma LNCaP cells [7] , and gently mixed. One tube of supplemented sample from each donor was processed immediately after preparation to serve as a positive control; the remaining ones were tested with various storage temperatures and delays. Five were sealed and left at room temperature (19 -22°C) for 3, 6, 9, 12, or 24 h. Eighteen, 9 refrigerated immediately at 4°C and another 9 mixed first with 2 volumes of NH 4 Cl (9 g/L) before cooling to 4°C, were left for 6 or 12 h, or 1, 2, 3, 6, 9, 12, or 15 days at the same temperature. Each blood sample was processed by the same protocol, as follows: Plasma was discarded and the remaining blood cells were diluted in 2 volumes of the NH 4 Cl solution and shaken overnight at 4°C. Each sample was then centrifuged at 1000g for 20 min and the supernatant removed. Total RNA was extracted from these cells by the guanidiumthiocyanate/phenol/chloroform extraction technique [8] . The RNA pellet obtained after ethanol/sodium acetate precipitation was dried under reduced pressure and dissolved in 50 L of RNase-free water; the yield of RNA was quantified by spectrophotometric analysis at 260 nm. RNA quality was evaluated by examining the average ratio of UV absorbance at 260 and 280 nm and then checked for purity by agarose gel analysis.
RT-PCR for PSA or PSMA was performed as previously described [9] , with normalization by amplification of ␤-globin [10] . Briefly, 1 g of total RNA was used for synthesis of the first strand of cDNA with SuperScript II reverse transcriptase and 100 ng oligo(dT) l2-18 as template (Life Technologies). Then, 1 L of cDNA was amplified by PCR by the following protocol: 94°C for 1 min (2 min for the first cycle); 62°C, 60°C, and 58°C for 1 min (for PSA, PSMA, and ␤-globin, respectively); and 72°C for 1 min (10 min for the last cycle) for 25 cycles. The PCR products (15 L) were run on ethidium bromide-stained agarose gels (20 g/L) and visualized by transillumination. Fluorescence was captured with a CCD camera and integrated by use of NIH Image 1.7 software. Statistical analysis of the results of three independent experiments performed in duplicate was done with GraphPad Prism/Stat software.
Room temperature (19 -23°C) storage of blood dramatically affected the RNA. Within 6 h, there was an important loss of RNA as indicated by UV quantification (Fig.  1A ) and confirmed by gel analysis (not shown). On samples stored from 6 to 24 h at room temperature, amplification of PSA and PSMA cDNAs was still possible but was impaired, as indicated by a decrease in the intensity of bands for PCR products (Fig. 1, B and C) . Extracting RNA from the 9 samples cooled immediately to 4°C gave comparable signals to those for samples stored 6 h to 6 days at that temperature. Amplification of both PSA (Fig. 1B) and PSMA (Fig. 1C) cDNAs also gave comparable results for the samples stored 6 h to 6 days. The decrease in PSMA cDNA signals in the samples stored for 12 or 15 days at 4°C apparently paralleled the decrease in PSA amplification and reflected loss of RNA after storage for Ͼ6 days. The immediate addition of ammonium chloride did not enhance the apparent stability of RNA, but PSMA and PSA amplifications were slightly lower in NH 4 Cl conditions than in the standard 4°C storage after 6 days or longer. This suggests a long-term inhibitory effect of NH 4 Cl on reverse transcriptase: (a) RNA amounts extracted were identical in the two groups of samples stored at 4°C, regardless of NH 4 Cl addition, and (b) no discrepant results were observed between PSA and PSMA cDNAs.
The current study demonstrates an important loss in RNA recovery within 6 h when samples are stored at room temperature. Stable results for at least 6 days are obtained when samples are immediately stored at 4°C after sampling. The length of the delay is of particular interest to laboratories receiving and processing blood samples stored for the day or sent at room temperature This study was supported in part by grants from Association de Recherche contre le Cancer (ARC 1367) and Association de Recherche sur les Tumeurs de la Prostate (ARTP). RNA was extracted as described and yield was measured by photometric absorbance at 260 nm. Band intensity was captured and integrated after electrophoresis on ethidium bromide-labeled 2% agarose gel. Each point represents the mean Ϯ SD of three independent experiments performed in duplicate. Significance shown above bars: 1, P Ͻ0.05; 2, P Ͻ0.01; 3, P Ͻ0.005; 4, P Ͻ0.001 (Student's unpaired t-test) when compared with RNA extraction or PSA and PSMA RT-PCR performed on samples with immediate processing.
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The nitric oxide radical (NO⅐) plays an important role as a physiological messenger [1] . NO is formed from l-arginine [2] by NO synthase (NOS; EC 1.14.13.39), which exists in several isoforms [3] . Constitutive calcium-dependent isoforms (cNOS) modulate the control of vascular tone in endothelial cells or the neurotransmission in neurons, whereas inducible calcium-independent isoforms (iNOS) are located in macrophages, chondrocytes, and hepatocytes and are induced by cytokines and endotoxin [4, 5] . Pathological conditions associated with increased release of cytokines and endotoxin, e.g., inflammation or sepsis [6] , can therefore increase NO production.
NO is a very unstable, short half-life gas that breaks down rapidly into the stable products nitrate and nitrite [7] . Upon coming into the bloodstream, nitrite reacts immediately with oxyhemoglobin to form methemoglobin. Consequently, most NO produced is detected in serum as the remaining product, nitrate [8] . Recently, several reports focused on methods to measure nitrate concentrations in biological fluids [9 -11] . One of the most commonly used methods is based on the reduction of nitrate to nitrite by cadmium or nitrate reductase, the nitrite produced being determined by Griess reaction [9, 12, 13] . Other methods for monitoring NO production are based on chemiluminescence [11, 14] , enzymatic assay with an internal standard [10] , or chromatographic procedures [8] for nitrate [15]-all of which are time-consuming for routine application in clinical chemistry laboratories.
We describe a rapid semiautomated method based on the Griess reaction, involving a shortened incubation period of nitrate with cadmium. The method is applicable to several types of biological fluids.
Serum or plasma samples from healthy individuals after a 12-h fast were obtained in accordance with the Medical Ethical Committee of our hospital. Samples were stored at Ϫ20°C and were stable for at least 6 months. The method was adapted to a Hitachi 717 Analyzer (Boehringer Mannheim). Cadmium granules were from Fluka. Copper sulfate, zinc sulfate, sulfanilic acid, glycine, ascorbic acid, sodium nitrite, and potassium nitrate were from Merck; sodium hydroxide, phosphoric acid, and hydrochloric acid from Panreac; and naphthylethylenediamine and lithium nitrate from Carlo Erba.
We deproteinized 300 L of serum or plasma by adding 250 L of 75 mmol/L ZnSO 4 solution, stirring, and centrifuging at 10 000g for at least 1 min at room temperature, after which 350 L of 55 mmol/L NaOH was added. Again, the solution was stirred and centrifuged at 10 000g for 3 min and the supernatant was recovered (the supernatant must be free of turbidity for measuring nitrate concentrations). We diluted 750 L of supernatant with 250 L of glycine buffer (45 g/L, pH 9.7).
For assay of urines, 100 L of urine was diluted with 900 L of the glycine buffer; for cerebrospinal fluid (CSF), 750 L was mixed with 250 L of the glycine buffer.
Cadmium granules (2-2.5 g) were rinsed three times with deionized distilled water and swirled in a 5 mmol/L CuSO 4 solution in glycine-NaOH buffer (15 g/L, pH 9.7) for 5 min. The copper-coated granules are to be used within 10 min. After use, the granules are rinsed and stored in 100 mmol/L H 2 SO 4 solution; they can be regenerated by repeating these steps.
Calibrators at various concentrations were prepared by diluting stock 20 mmol/L solutions of NaNO 2 , KNO 3 , or LiNO 3 with deionized distilled water. The nitrate calibrators were diluted with glycine buffer just as the serum samples were. Calibration curves were made over a linear range of nitrate between 0 and 100 mol/L.
Freshly activated cadmium granules (2-2.5 g) were added to 1 mL of pretreated deproteinized serum, urine, CSF, or calibrator. After continuous stirring for 10 min, the samples were transferred to appropriately labeled tubes for nitrite determination.
Reagent 1 consisted of 50 mg of N-naphthylethylenediamine dissolved in 250 mL of distilled water. Reagent 2 was prepared by dissolving 5 g of sulfanilic acid in 500 mL of 3 mol/L HCl. Both solutions are stable for at least a year at 4°C. Results were expressed as the mean of duplicate determinations. New calibration curves were calculated for each batch of samples. The instrument settings for the method, shown in Table 1 The reduction of nitrate at concentrations of 10, 30, and 50 mol/L was complete within 10 min at room temperature (Fig. 1) . To confirm the completion of the reduction of nitrate to nitrite, we added nitrite, 15 mol/L, to the three nitrate solutions. Before reduction, nitrite concentrations were 15.5, 15.1, and 15.8 mol/L, respectively. After 10 min of reduction, concentrations were 25.8, 45.7, and 66 mol/L, respectively, indicating that the reduction was complete.
The reaction was linear with concentrations of nitrate calibrator up to 600 mol/L: y ϭ 0.0019x ϩ 0.0022 (r ϭ 0.9999, S y͉x ϭ 0.001). The detection limit of the assay, i.e., the concentration corresponding to the mean Ϯ 3 SD (n ϭ
